Robust Optimization for Intensity Modulated Proton Therapy to Redistribute High Linear Energy Transfer from Nearby Critical Organs to Tumors in Head and Neck Cancer.


Journal

International journal of radiation oncology, biology, physics
ISSN: 1879-355X
Titre abrégé: Int J Radiat Oncol Biol Phys
Pays: United States
ID NLM: 7603616

Informations de publication

Date de publication:
01 05 2020
Historique:
received: 22 05 2019
revised: 08 01 2020
accepted: 14 01 2020
pubmed: 29 1 2020
medline: 6 10 2020
entrez: 29 1 2020
Statut: ppublish

Résumé

We propose linear energy transfer (LET)-guided robust optimization in intensity modulated proton therapy for head and neck cancer. This method simultaneously considers LET and physical dose distributions of tumors and organs at risk (OARs) with uncertainties. Fourteen patients with head and neck cancer were included in this retrospective study. Cord, brain stem, brain, and oral cavity were considered. Two algorithms, voxel-wise worst-case robust optimization and LET-guided robust optimization (LETRO), were used to generate intensity modulated proton therapy plans for each patient. The latter method directly optimized LET distributions rather than indirectly as in previous methods. LET-volume histograms (LETVHs) were generated, and high LET was redistributed from nearby OARs to tumors in a user-defined way via LET-volume constraints. Dose-volume histogram indices, such as clinical target volume (CTV) D In the nominal scenario, LETRO provided higher LET distributions in the CTV (unit: keV/μm; CTV LET LETRO robustly optimized LET and physical dose distributions simultaneously. It redistributed high LET from OARs to targets with slightly modified physical dose and plan robustness.

Identifiants

pubmed: 31987967
pii: S0360-3016(20)30072-9
doi: 10.1016/j.ijrobp.2020.01.013
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

181-193

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Chenbin Liu (C)

Department of Radiation Oncology, Mayo Clinic in Arizona, Phoenix, Arizona.

Samir H Patel (SH)

Department of Radiation Oncology, Mayo Clinic in Arizona, Phoenix, Arizona.

Jie Shan (J)

Department of Radiation Oncology, Mayo Clinic in Arizona, Phoenix, Arizona.

Steven E Schild (SE)

Department of Radiation Oncology, Mayo Clinic in Arizona, Phoenix, Arizona.

Carlos E Vargas (CE)

Department of Radiation Oncology, Mayo Clinic in Arizona, Phoenix, Arizona.

William W Wong (WW)

Department of Radiation Oncology, Mayo Clinic in Arizona, Phoenix, Arizona.

Xiaoning Ding (X)

Department of Radiation Oncology, Mayo Clinic in Arizona, Phoenix, Arizona.

Martin Bues (M)

Department of Radiation Oncology, Mayo Clinic in Arizona, Phoenix, Arizona.

Wei Liu (W)

Department of Radiation Oncology, Mayo Clinic in Arizona, Phoenix, Arizona. Electronic address: liu.wei@mayo.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH